C4 Therapeutics, Inc.CCCCNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank71
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-1.36
↑ 19% vs avg
Percentile
P71
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-1.67
Historical baseline
PeriodValueYoY Change
TTM-1.36+10.5%
2024-1.52+43.1%
2023-2.67-1.9%
2022-2.62-44.0%
2021-1.82-18.2%
2020-1.54-94.9%
2019-0.79+25.5%
2018-1.06-